Bremer Trust National Association’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | $1.76M | Buy |
18,045
+1,346
| +8% | +$131K | 0.38% | 71 |
|
|
2018
Q3 | $2.32M | Buy |
16,699
+3,678
| +28% | +$511K | 0.58% | 40 |
|
|
2018
Q2 | $1.62M | Buy |
13,021
+9,792
| +303% | +$1.22M | 0.45% | 58 |
|
|
2018
Q1 | $360K | Sell |
3,229
-939
| -23% | -$105K | 0.1% | 168 |
|
|
2017
Q4 | $498K | Buy |
4,168
+69
| +2% | +$8.24K | 0.13% | 147 |
|
|
2017
Q3 | $575K | Sell |
4,099
-260
| -6% | -$36.5K | 0.16% | 133 |
|
|
2017
Q2 | $531K | Sell |
4,359
-1,125
| -21% | -$137K | 0.15% | 138 |
|
|
2017
Q1 | $665K | Buy |
5,484
+94
| +2% | +$11.4K | 0.18% | 124 |
|
|
2016
Q4 | $660K | Sell |
5,390
-88
| -2% | -$10.8K | 0.18% | 134 |
|
|
2016
Q3 | $672K | Buy |
5,478
+26
| +0.5% | +$3.19K | 0.18% | 132 |
|
|
2016
Q2 | $637K | Sell |
5,452
-118
| -2% | -$13.8K | 0.18% | 118 |
|
|
2016
Q1 | $776K | Buy |
5,570
+148
| +3% | +$20.6K | 0.22% | 105 |
|
|
2015
Q4 | $1.03M | Sell |
5,422
-226
| -4% | -$43.1K | 0.31% | 85 |
|
|
2015
Q3 | $883K | Sell |
5,648
-1,010
| -15% | -$158K | 0.29% | 89 |
|
|
2015
Q2 | $1.2M | Buy |
6,658
+4
| +0.1% | +$723 | 0.36% | 73 |
|
|
2015
Q1 | $1.15M | Buy |
6,654
+579
| +10% | +$100K | 0.37% | 73 |
|
|
2014
Q4 | $1.12M | Buy |
6,075
+599
| +11% | +$111K | 0.36% | 70 |
|
|
2014
Q3 | $908K | Buy |
5,476
+3
| +0.1% | +$497 | 0.31% | 81 |
|
|
2014
Q2 | $855K | Sell |
5,473
-701
| -11% | -$110K | 0.3% | 82 |
|
|
2014
Q1 | $940K | Sell |
6,174
-315
| -5% | -$48K | 0.35% | 68 |
|
|
2013
Q4 | $863K | Sell |
6,489
-232
| -3% | -$30.9K | 0.33% | 69 |
|
|
2013
Q3 | $781K | Buy |
6,721
+9
| +0.1% | +$1.05K | 0.33% | 73 |
|
|
2013
Q2 | $619K | Buy |
+6,712
| New | +$619K | 0.28% | 83 |
|